Drug price fixing lawsuit
Six Antitrust Lawsuits Allege Drug Price-Fixing
June 7, 2017
Six separate lawsuits filed in a Pennsylvania court allege that a group of pharmaceutical manufacturers conspired to inflate the prices of several muscle relaxers, skin creams, antidepressants, and blood pressure drugs. The cases were filed as part of a Multi-District Litigation (MDL) in federal court.
The cases allege that the drug companies thus forced retailers to pay unfairly high prices for such drugs as the muscle relaxer Baclofen, the skin cream Desonide, and several generic medications.
Named in the suits are drug makers Mylan, Fougera Pharmaceuticals, Par Pharmaceuticals, Teva Pharmaceuticals, Upsher-Smith Laboratories, Taro Pharmaceutical Industries, as well as numerous of these companies’ parent companies and subsidiaries.
The suits were brought by KPH Healthcare Services, the company that owns and operates the Kinney Drugs chain of stores.
In the case of baclofen, one of the suits alleges, the price for 10-milligram tablets had been stable until April 2014, when it suddenly rose more than 600 percent. Prices of the topical cream Desonide experienced a similarly explosive jump, one of the suits states. A 60-gram tube of the cream cost $26.75 at the beginning of 2013; by year’s end, the price had leaped to $225.
Each of the complaints claims that, over the time in which their prices jumped, none of the named medications experienced no increases in manufacturing costs nor shortages of ingredients. Further, the suits allege, the prices of these and other medications would have remained stable had there not been an antitrust conspiracy in operation.
The attorneys at TheLawFirm.com are experts in Multi-District Litigation cases. If you think you have a case against Big Pharma, contact us. The consultation is free, and we can help.
Talk with aN Attorney now!
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!